Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.
暂无分享,去创建一个
[1] R. Zhou,et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity , 2011, Proceedings of the National Academy of Sciences.
[2] Jennifer E Gagner,et al. Effect of gold nanoparticle morphology on adsorbed protein structure and function. , 2011, Biomaterials.
[3] Á. González-Fernández,et al. Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro. , 2011, Nanomedicine.
[4] Iseult Lynch,et al. The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.
[5] Richard C Zangar,et al. Cellular recognition and trafficking of amorphous silica nanoparticles by macrophage scavenger receptor A , 2011, Nanotoxicology.
[6] Morteza Mahmoudi,et al. Engineered nanoparticles for biomolecular imaging. , 2011, Nanoscale.
[7] Carlo Crescenzi,et al. Shotgun proteomic analytical approach for studying proteins adsorbed onto liposome surface , 2011, Analytical and bioanalytical chemistry.
[8] Shaoyi Jiang,et al. Multifunctional and degradable zwitterionic nanogels for targeted delivery, enhanced MR imaging, reduction-sensitive drug release, and renal clearance. , 2011, Biomaterials.
[9] Stefano Corni,et al. Simulation of Peptide–Surface Recognition , 2011 .
[10] Ranjita Shegokar,et al. In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[11] P. Chakrabarti,et al. Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[12] Minnamari Vippola,et al. Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. , 2011, ACS nano.
[13] J. Schlenoff,et al. Zwitteration as an alternative to PEGylation. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[14] T. Ishida,et al. Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[15] P. Wentworth,et al. A shotgun proteomic study of the protein corona associated with cholesterol and atheronal-B surface-modified quantum dots. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] Kazuo Maruyama,et al. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.
[17] Katharina Landfester,et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. , 2011, ACS nano.
[18] De-Hao Tsai,et al. Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[19] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[20] R. Amal,et al. Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). , 2011, Langmuir : the ACS journal of surfaces and colloids.
[21] Gerard W. Doorley,et al. Cellular binding of nanoparticles in the presence of serum proteins. , 2011, Chemical communications.
[22] Irene Yarovsky,et al. Ordering surfaces on the nanoscale: implications for protein adsorption. , 2011, Journal of the American Chemical Society.
[23] Istvan Toth,et al. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.
[24] Adam J. Makarucha,et al. Nanomaterials in biological environment: a review of computer modelling studies , 2011, European Biophysics Journal.
[25] Iseult Lynch,et al. Serum heat inactivation affects protein corona composition and nanoparticle uptake. , 2010, Biomaterials.
[26] Roberto Cingolani,et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.
[27] Ruhong Zhou,et al. Plugging into proteins: poisoning protein function by a hydrophobic nanoparticle. , 2010, ACS nano.
[28] David M. Brown,et al. The effects of serum on the toxicity of manufactured nanoparticles. , 2010, Toxicology letters.
[29] J. Schlenoff,et al. Zwitterion-stabilized silica nanoparticles: toward nonstick nano. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[30] Giulio Caracciolo,et al. Analysis of plasma protein adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer , 2010, Analytical and bioanalytical chemistry.
[31] G. Raffaini,et al. Protein Adsorption on Biomaterial and Nanomaterial Surfaces: A Molecular Modeling Approach to Study Non-Covalent Interactions , 2010, Journal of applied biomaterials & biomechanics : JABB.
[32] Jim E Riviere,et al. An index for characterization of nanomaterials in biological systems. , 2010, Nature nanotechnology.
[33] Ivo Atanasov,et al. Atomic Structure of Human Adenovirus by Cryo-EM Reveals Interactions Among Protein Networks , 2010, Science.
[34] S Kundhavai Natchiar,et al. Crystal Structure of Human Adenovirus at 3.5 Å Resolution , 2010, Science.
[35] U. Schubert,et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.
[36] Leaf Huang,et al. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[37] Bing Yan,et al. Analytical strategies for detecting nanoparticle-protein interactions. , 2010, The Analyst.
[38] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[39] Sara Linse,et al. Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid , 2010, PloS one.
[40] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[41] Z. Lenkei,et al. Small and stable sulfobetaine zwitterionic quantum dots for functional live-cell imaging. , 2010, Journal of the American Chemical Society.
[42] Jack F Douglas,et al. Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.
[43] J. Koziol,et al. Label-free, normalized quantification of complex mass spectrometry data for proteomics analysis , 2009, Nature Biotechnology.
[44] Liping Tang,et al. Nanomaterial cytotoxicity is composition, size, and cell type dependent , 2010, Particle and Fibre Toxicology.
[45] Mark E. Davis,et al. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.
[46] Darren J. Martin,et al. Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.
[47] T. Niidome,et al. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[48] Wolfgang J Parak,et al. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.
[49] Ji-Ho Park,et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.
[50] Stefano Corni,et al. GolP: An atomistic force‐field to describe the interaction of proteins with Au(111) surfaces in water , 2009, J. Comput. Chem..
[51] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[52] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[53] Sara Linse,et al. Complete high‐density lipoproteins in nanoparticle corona , 2009, The FEBS journal.
[54] Mauro Ferrari,et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. , 2009, Biomaterials.
[55] Warren C W Chan,et al. Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.
[56] Timothy J Shaw,et al. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. , 2009, Small.
[57] Chad A Mirkin,et al. The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles. , 2009, ACS nano.
[58] J. Dordick,et al. Cytochrome C on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity. , 2009, Small.
[59] Alexander Kabanov,et al. Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles , 2009, PloS one.
[60] James L. McGrath,et al. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.
[61] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[62] Robert A Latour,et al. Molecular simulation of protein-surface interactions: Benefits, problems, solutions, and future directions (Review) , 2008, Biointerphases.
[63] James M. Anderson,et al. Foreign body reaction to biomaterials. , 2008, Seminars in immunology.
[64] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[65] Shaoyi Jiang,et al. Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma. , 2008, Biomacromolecules.
[66] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[67] Hongyu Zhou,et al. A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response. , 2008, Nano letters.
[68] L. Unsworth,et al. Protein-resistant poly(ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[69] M. Textor,et al. Poly-2-methyl-2-oxazoline: a peptide-like polymer for protein-repellent surfaces. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[70] Sara Linse,et al. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.
[71] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[72] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[73] K. Higaki,et al. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. , 2007, International journal of pharmaceutics.
[74] V. Rotello,et al. Biomimetic interactions of proteins with functionalized nanoparticles: a thermodynamic study. , 2007, Journal of the American Chemical Society.
[75] G. Cagney,et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.
[76] P. Couvreur,et al. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system , 2007, Electrophoresis.
[77] Seishiro Hirano,et al. A murine scavenger receptor MARCO recognizes polystyrene nanoparticles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[78] K. Dawson,et al. Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. , 2007, Nano letters.
[79] Patrick Couvreur,et al. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. , 2007, Biomacromolecules.
[80] T. Forte,et al. The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. , 2007, Biochemistry.
[81] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[82] Robert Langer,et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.
[83] Ravi S Kane,et al. Nanobiotechnology: Protein‐Nanomaterial Interactions , 2007, Biotechnology progress.
[84] John W. Earl,et al. Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases , 2007, European Journal of Clinical Pharmacology.
[85] Jean-Pierre Benoit,et al. Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.
[86] David Farrar,et al. Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. , 2006, Journal of the American Chemical Society.
[87] Malcolm L. H. Green,et al. Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.
[88] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[89] R. Müller,et al. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. , 2006, Biomaterials.
[90] Kimberly Hamad-Schifferli,et al. Gold nanoparticle-cytochrome C complexes: the effect of nanoparticle ligand charge on protein structure. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[91] R. Müller,et al. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. , 2005, International journal of pharmaceutics.
[92] R. Müller,et al. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[93] R. Müller,et al. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. , 2005, Biomaterials.
[94] J. Kamps,et al. ERRATUM The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse (vol 328, pg 57, 2005) , 2005 .
[95] David Farrar,et al. Interpretation of protein adsorption: surface-induced conformational changes. , 2005, Journal of the American Chemical Society.
[96] R. Müller,et al. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.
[97] A. C. Hunter,et al. Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[98] R. Müller,et al. In vitro adsorption of plasma proteins onto the surface (charges) modified-submicron emulsions for intravenous administration. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[99] Polly Matzinger,et al. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.
[100] Jonathan S Dordick,et al. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[101] R. Müller,et al. Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[102] R. Müller,et al. Drug delivery to the brain--realization by novel drug carriers. , 2004, Journal of nanoscience and nanotechnology.
[103] T. Veenstra,et al. The Human Plasma Proteome , 2004, Molecular & Cellular Proteomics.
[104] Todd Emrick,et al. Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. , 2004, Journal of the American Chemical Society.
[105] W. Semmler,et al. Determination of Plasma Protein Adsorption on Magnetic Iron Oxides: Sample Preparation , 1997, Pharmaceutical Research.
[106] G. Borchard,et al. The Role of Serum Complement on the Organ Distribution of Intravenously Administered Poly (methyl methacrylate) Nanoparticles: Effects of Pre-Coating with Plasma and with Serum Complement , 1996, Pharmaceutical Research.
[107] Allan G. A. Coombes,et al. Surface Modification of Poly(lactide-co-glycolide) Nanospheres by Biodegradable Poly(lactide)-Poly(ethylene glycol) Copolymers , 1994, Pharmaceutical Research.
[108] Hideyoshi Harashima,et al. Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes , 1994, Pharmaceutical Research.
[109] S. Moein Moghimi,et al. Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups , 2004, Pharmaceutical Research.
[110] R. Müller,et al. Influence of Fluorescent Labelling of Polystyrene Particles on Phagocytic Uptake, Surface Hydrophobicity, and Plasma Protein Adsorption , 2004, Pharmaceutical Research.
[111] Feng Liu,et al. Antibody Dependent, Complement Mediated Liver Uptake of Liposomes Containing GM1 , 2004, Pharmaceutical Research.
[112] S. Wright,et al. Role of Complements C3 and C5 in the Phagocytosis of Liposomes by Human Neutrophils , 2004, Pharmaceutical Research.
[113] Rainer H Müller,et al. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. , 2003, Journal of biomedical materials research. Part A.
[114] R. Müller,et al. Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions. , 2003, International journal of pharmaceutics.
[115] Hongzhe Sun,et al. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.
[116] T. Ugarova,et al. Regulated Unmasking of the Cryptic Binding Site for Integrin αMβ2 in the γC-Domain of Fibrinogen† , 2002 .
[117] R. Müller,et al. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[118] Bo Nilsson,et al. C3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase1 , 2002, The Journal of Immunology.
[119] Y. Heng,et al. Towards practical soft X-ray spectromicroscopy of biomaterials , 2002, Journal of biomaterials science. Polymer edition.
[120] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[121] J. Kreuter,et al. Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.
[122] B. Schwikowski,et al. A network of protein–protein interactions in yeast , 2000, Nature Biotechnology.
[123] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[124] W. Norde,et al. BSA structural changes during homomolecular exchange between the adsorbed and the dissolved states. , 2000, Journal of biotechnology.
[125] R. Müller,et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.
[126] R. Müller,et al. Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[127] P Couvreur,et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. , 1999, Biomaterials.
[128] P. Couvreur,et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[129] C. Costa Vera,et al. Conformational stability of adsorbed insulin studied with mass spectrometry and hydrogen exchange. , 1999, Analytical chemistry.
[130] R. J. Green,et al. Competitive protein adsorption as observed by surface plasmon resonance. , 1999, Biomaterials.
[131] M. Lück,et al. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[132] H. Harashima,et al. Identification of proteins mediating clearance of liposomes using a liver perfusion system. , 1998, Advanced drug delivery reviews.
[133] P. Cullis,et al. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. , 1998, Advanced drug delivery reviews.
[134] M. Lück,et al. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. , 1998, Journal of biomedical materials research.
[135] J. Szebeni,et al. The interaction of liposomes with the complement system. , 1998, Critical reviews in therapeutic drug carrier systems.
[136] L. Balant,et al. Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement. , 1997, Journal of biomedical materials research.
[137] R. Weissleder,et al. Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages , 1997, Journal of magnetic resonance imaging : JMRI.
[138] P. Tengvall,et al. In Vitro Plasma Protein Adsorption on ω-Functionalized Alkanethiolate Self-Assembled Monolayers , 1997 .
[139] I. Szleifer,et al. Protein adsorption on surfaces with grafted polymers: a theoretical approach. , 1997, Biophysical journal.
[140] R. Müller,et al. Identification of plasma proteins facilitated by enrichment on particulate surfaces: Analysis by two‐dimensional electrophoresis and N‐terminal microsequencing , 1997, Electrophoresis.
[141] H. Elwing,et al. Complement activation on thiol-modified gold surfaces. , 1996, Journal of biomedical materials research.
[142] D. Hochstrasser,et al. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting , 1996 .
[143] H. Kiwada,et al. Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum. , 1995, Biological & pharmaceutical bulletin.
[144] Dexi Liu,et al. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. , 1995, Biochimica et biophysica acta.
[145] D. Devine,et al. Liposome-complement interactions in rat serum: implications for liposome survival studies. , 1994, Biochimica et biophysica acta.
[146] W. Norde,et al. Protein adsorption at solid surfaces: A thermodynamic approach , 1994 .
[147] K. Funato,et al. The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ. , 1994, Journal of drug targeting.
[148] V. Kolb-Bachofen,et al. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.
[149] D. Hochstrasser,et al. Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.
[150] K. Higashitani,et al. Circular dichroism studies on conformational changes in protein molecules upon adsorption on ultrafine polystyrene particles , 1992, Biotechnology and bioengineering.
[151] R. E. Pitas,et al. Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. , 1992, Biochimica et biophysica acta.
[152] P. Cullis,et al. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. , 1992, The Journal of biological chemistry.
[153] J H Senior,et al. Interaction of positively-charged liposomes with blood: implications for their application in vivo. , 1991, Biochimica et biophysica acta.
[154] S. Davis,et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.
[155] V. Torchilin,et al. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.
[156] H. Arai,et al. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. , 1990, The Journal of biological chemistry.
[157] P. Artursson,et al. Receptor-mediated uptake of starch and mannan microparticles by macrophages: relative contribution of receptors for complement, immunoglobulins and carbohydrates. , 1988, Biomaterials.
[158] P. Courtoy,et al. A model of protein-colloidal gold interactions. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[159] G. Scherphof,et al. Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro. , 1987, Experimental cell research.
[160] R. Mahley,et al. Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.
[161] R. Juliano,et al. Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. , 1982, Biochimica et biophysica acta.
[162] L. Vroman,et al. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. , 1980, Blood.
[163] Y. Tani,et al. Bacterial oxidation of polyethylene glycol , 1978, Applied and environmental microbiology.